Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nerandomilast Added to Mycophenolate for Treatment of Pulmonary Fibrosis (NERAM-PF).

NCT07570888 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT07570888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07570888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nerandomilast Added to Mycophenolate for Treatment of Pulmonary Fibrosis (NERAM-PF).
Lead sponsor
University of British Columbia
Phase
Phase 4
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
July 31, 2027
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease (ild), pulmonary fibrosis